EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2026-02-12
Management highlights
Management Statement and Operational Highlights
- Portfolio Rotation: Rotated 15% of the total portfolio in 2025 through the successful demerger of Ice Cream and 10 deals including acquisitions and disposals of non-strategic brands.
- Innovation: Elevated brand offerings through strong innovation plans and a shift to social-first demand generation models, improving brand superiority scores.
- Execution: Strong in developed markets, improved in emerging markets; corrected performance gaps in areas like Home Care and Deodorants in Brazil and U.S. businesses.
- Cost Discipline: Drove cost discipline with the productivity program delivering 50 basis points overhead improvement, ahead of schedule.
Segment performance
Segment Performance
- Beauty & Wellbeing: Underlying sales growth was 4.3% in 2025, with volumes at 2.2% and price at 2.1%. Over a 2-year period, compounded annual volume growth was 3.3%. Underlying operating profit was EUR 2.5 billion with an underlying operating margin of 19.2%.
- Personal Care: Underlying sales growth was 4.7% in 2025, with volumes at 1.1% and price at 3.6%. Over a 2-year period, compounded annual volume growth was 3.1%. Underlying operating profit was EUR 3 billion with an underlying operating margin of 22.6%.
- Home Care: Underlying sales growth was 2.6% in 2025, with volumes at 2.2% and price at 0.4%. Over a 2-year period, compounded annual volume growth was 3.1%. Underlying operating profit was EUR 1.7 billion with an underlying operating margin of 14.9%.
- Foods: Underlying sales growth was 2.5% in 2025, with volumes at 0.8% and price at 1.7%. Over a 2-year period, compounded annual volume growth was 3.6%. Underlying operating profit was EUR 2.9 billion with an underlying operating margin of 22.6%.
Guidance
Guidance
- Expect underlying sales growth for the full year 2026 to be at the bottom end of the multiyear range of 4% to 6%.
- Expect underlying volume growth of at least 2%.
- Confident of a further modest improvement to the underlying operating margin.
- Announced a new share buyback of EUR 1.5 billion.
Risks
Risks
- Currency Headwinds: Significant currency headwinds reduced turnover by 5.9% in 2025, with a weaker U.S. dollar and depreciation in emerging market currencies.
- Market Volatility: Market growth moderated in some segments, with softer conditions in certain emerging markets and developed markets in the second half.
- Commodity Inflation: Concentrated commodity inflation in materials like palm, canola oil, and surfactants, with wage inflation also posing challenges.
Q&A highlights
Question and Answer
Q: Can you talk a bit about the emerging market outlook for 2026?
A: Emerging markets are seen as a long-term competitive advantage. India, China, Indonesia are showing improvements; LatAm market volume growth remains flattish but expect improvements in 2026.
Q: What's the outlook for pricing in 2026?
A: Expect pricing to be around 2% level, with commodity inflation concentrated in certain materials and some deflation in others.
Q: Details on Europe's performance and Power Brands vs non-Power Brands?
A: Europe saw some slowdown, but Home Care and Personal Care performed well. Power Brands (78% of revenue) grew strongly, non-Power Brands (22%) had lower growth but managed accordingly.
Q: Sequencing of growth for 2026 and Wellbeing/Beauty category?
A: Guiding top line growth at lower end of range, with Beauty & Wellbeing showing solid performance; Wellbeing had some softening but confident in structural growth.
Q: Update on innovation and TSA for Magnum?
A: Focus on investing in successful innovations; TSA for Magnum has clear plans with tapering off expected and no stranded costs for Unilever.
Q: Strategy for Prestige Beauty and Foods margins?
A: Prestige Beauty focused on digital-native brands and e-commerce; Foods margins benefited from portfolio rationalization, execution discipline, and overhead savings, with focus on growth.
Q: Impact of discontinuations and Dr. Squatch?
A: Discontinuations in non-Power Brands; Dr. Squatch acquired, performing well and expected to contribute to growth from September 2026.
Q: Latin America's recovery and channel shift in North America?
A: Latin America showing improvement with interventions in Home Care and Deos; North America has strong digital commerce growth with focus on digitally-native brands.
Q: 2026 benefits of revamped innovation and CapEx plans?
A: 2026 expected to bear fruits of innovation investment; CapEx plans to spend 55%-60% on margin-enhancing activities with strict business case justification.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $1.37 | $1.75 | -21.7% | $0.84 |
| Revenue | $23.93B | $14.77B | +62.0% | $30.70B |
Transcript
February 12, 2026Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.